User profiles for Stefanie Menzies
 | Stefanie MenziesPostdoctoral Research Associate, Washington University in St Louis Verified email at wustl.edu Cited by 597 |
An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving …
Background The World Health Organization’s strategy to halve snakebite mortality and
morbidity by 2030 includes an emphasis on a risk-benefit process assessing the preclinical …
morbidity by 2030 includes an emphasis on a risk-benefit process assessing the preclinical …
Risk factors for soil-transmitted helminth infections during the first 3 years of life in the tropics; findings from a birth cohort
SK Menzies, A Rodriguez, M Chico… - PLoS neglected …, 2014 - journals.plos.org
Background Soil-transmitted helminths (STH) infect more than 2 billion humans worldwide,
causing significant morbidity in children. There are few data on the epidemiology and risk …
causing significant morbidity in children. There are few data on the epidemiology and risk …
[HTML][HTML] In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by …
Snakebite envenoming affects more than 250,000 people annually in sub-Saharan Africa.
Envenoming by Dispholidus typus (boomslang) results in venom-induced consumption …
Envenoming by Dispholidus typus (boomslang) results in venom-induced consumption …
Photo-affinity labelling and biochemical analyses identify the target of trypanocidal simplified natural product analogues
LB Tulloch, SK Menzies, AL Fraser… - PLoS Neglected …, 2017 - journals.plos.org
Current drugs to treat African sleeping sickness are inadequate and new therapies are
urgently required. As part of a medicinal chemistry programme based upon the simplification of …
urgently required. As part of a medicinal chemistry programme based upon the simplification of …
[HTML][HTML] Saliva alternative to upper respiratory swabs for SARS-CoV-2 diagnosis
PCR of upper respiratory specimens is the diagnostic standard for severe acute respiratory
syndrome coronavirus 2 infection. However, saliva sampling is an easy alternative to nasal …
syndrome coronavirus 2 infection. However, saliva sampling is an easy alternative to nasal …
Self-sampling of capillary blood for SARS-CoV-2 serology
Serological testing is emerging as a powerful tool to progress our understanding of COVID-19
exposure, transmission and immune response. Large-scale testing is limited by the need …
exposure, transmission and immune response. Large-scale testing is limited by the need …
[HTML][HTML] IgG seroconversion and pathophysiology in severe acute respiratory syndrome coronavirus 2 infection
…, DC Macallan, J Mensah-Kane, S Menzies… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We investigated the dynamics of seroconversion in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …
Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections
…, Z Lewis, DC Macallan, J Mensah-Kane, S Menzies… - MedRxiv, 2020 - medrxiv.org
We report dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …
Next-Generation sequencing for venomics: application of multi-enzymatic limited digestion for inventorying the snake venom arsenal
…, L Freuville, D Baiwir, G Mazzucchelli, SK Menzies… - Toxins, 2023 - mdpi.com
To improve the characterization of snake venom protein profiles, we report the application of
a new generation of proteomic methodology to deeply characterize complex protein …
a new generation of proteomic methodology to deeply characterize complex protein …
The trypanosome alternative oxidase: a potential drug target?
New drugs against Trypanosoma brucei, the causative agent of Human African Trypanosomiasis,
are urgently needed to replace the highly toxic and largely ineffective therapies …
are urgently needed to replace the highly toxic and largely ineffective therapies …
